Editas Medicine Inc buy Slaandjivaa
Start price
22.01.18
/
50%
€30.80
Target price
23.07.18
€34.28
Performance (%)
6.15%
End price
23.07.18
€32.70
Summary
This prediction ended on 23.07.18 with a price of €32.70. The BUY prediction by Slaandjivaa finished with a performance of 6.15%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | 0.410% | 0.410% | -5.551% | -68.630% |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by Slaandjivaa for this prediction
In the thread Editas Medicine Inc diskutieren
Edit besser als Crispr?
(Laufzeit überschritten)


